Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Vellenga

Showing results (31-40 of 244) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|July 23, 1983
Effective prophylaxis with oral anticoagulants and low-dose heparin during pregnancy in an antithrombin III deficient womanE Vellenga, G W van Imhoff, J G Aarnoudse
Experimental Hematology|July 1, 1987
Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF)E Vellenga, H R Delwel, I P Touw, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factorsC A Uyl-de Groot, E Vellenga, F F Rutten
The Journal of Biological Chemistry|May 4, 2001
Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivationJ J Schuringa, L V Dekker, E Vellenga, et al.
British Journal of Haematology|February 13, 2001
Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3)P K Wierenga, R Setroikromo, E Vellenga, et al.
Blood|June 14, 2000
Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6J J Schuringa, A T Wierenga, W Kruijer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 10, 2000
Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathwayP Borger, D S Postma, E Vellenga, et al.
Bone Marrow Transplantation|December 24, 1997
Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literatureS Hovenga, J T de Wolf, H Klip, et al.
European Cytokine Network|December 10, 1999
Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5K U Birkenkamp, M T Esselink, W Kruijer, et al.
Infection|January 4, 2001
Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?E S de Bont, E Vellenga, J Swaanenburg, et al.
Pageof 25

Showing results (31-40 of 244) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|July 23, 1983
Effective prophylaxis with oral anticoagulants and low-dose heparin during pregnancy in an antithrombin III deficient womanE Vellenga, G W van Imhoff, J G Aarnoudse
Experimental Hematology|July 1, 1987
Patterns of acute myeloid leukemia colony growth in response to recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF)E Vellenga, H R Delwel, I P Touw, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
An economic model to assess the savings from a clinical application of haematopoietic growth factorsC A Uyl-de Groot, E Vellenga, F F Rutten
The Journal of Biological Chemistry|May 4, 2001
Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cdelta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivationJ J Schuringa, L V Dekker, E Vellenga, et al.
British Journal of Haematology|February 13, 2001
Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3)P K Wierenga, R Setroikromo, E Vellenga, et al.
Blood|June 14, 2000
Constitutive Stat3, Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6J J Schuringa, A T Wierenga, W Kruijer, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|June 10, 2000
Regulation of asthma-related T-cell cytokines by the cyclic AMP-dependent signalling pathwayP Borger, D S Postma, E Vellenga, et al.
Bone Marrow Transplantation|December 24, 1997
Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literatureS Hovenga, J T de Wolf, H Klip, et al.
European Cytokine Network|December 10, 1999
Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5K U Birkenkamp, M T Esselink, W Kruijer, et al.
Infection|January 4, 2001
Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever?E S de Bont, E Vellenga, J Swaanenburg, et al.
Pageof 25